NPM1 and acute myeloid leukemia: The FLT3-ITD and NPM1 p.W288fs (TCTG insertion) mutations are inarguably defined as AML driver mutations, as numerous studies have demonstrated their co-occurrence in AML patients [17, 20, 29, 30].